Wegovy Brand-name injectable semaglutide FDA-approved for chronic weight management
Projected Weight Loss by Starting Weight Based on Phase 3 data (12 mg dose, 68 weeks, 28.7% mean weight loss): averages based on the TRIUMPH-4 mean
Reconstituted vials refrigerated only, used within ~28 days
Why advancing is key The goal of oral drug technologies is to beat GLP1s' fragility in the digestive tract, potentially replacing injections for many patients by improving convenience and adherence
However, if its not right for you, our healthcare team will help you explore other options based on your medical history and goals
Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat